Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression.
Wall MJ, Hill E, Huckstepp R, Barkan K, Deganutti G, Leuenberger M, Preti B, Winfield I, Carvalho S, Suchankova A, Wei H, Safitri D, Huang X, Imlach W, La Mache C, Dean E, Hume C, Hayward S, Oliver J, Zhao FY, Spanswick D, Reynolds CA, Lochner M, Ladds G, Frenguelli BG. Wall MJ, et al. Among authors: barkan k. Nat Commun. 2022 Jul 18;13(1):4150. doi: 10.1038/s41467-022-31652-2. Nat Commun. 2022. PMID: 35851064 Free PMC article.
Deciphering the Agonist Binding Mechanism to the Adenosine A1 Receptor.
Deganutti G, Barkan K, Preti B, Leuenberger M, Wall M, Frenguelli BG, Lochner M, Ladds G, Reynolds CA. Deganutti G, et al. Among authors: barkan k. ACS Pharmacol Transl Sci. 2021 Jan 21;4(1):314-326. doi: 10.1021/acsptsci.0c00195. eCollection 2021 Feb 12. ACS Pharmacol Transl Sci. 2021. PMID: 33615181 Free PMC article.
Multisite Model of Allosterism for the Adenosine A1 Receptor.
Deganutti G, Barkan K, Ladds G, Reynolds CA. Deganutti G, et al. Among authors: barkan k. J Chem Inf Model. 2021 Apr 26;61(4):2001-2015. doi: 10.1021/acs.jcim.0c01331. Epub 2021 Mar 29. J Chem Inf Model. 2021. PMID: 33779168
Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure-Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations.
Stampelou M, Suchankova A, Tzortzini E, Dhingra L, Barkan K, Lougiakis N, Marakos P, Pouli N, Ladds G, Kolocouris A. Stampelou M, et al. Among authors: barkan k. J Med Chem. 2022 Oct 13;65(19):13305-13327. doi: 10.1021/acs.jmedchem.2c01123. Epub 2022 Sep 29. J Med Chem. 2022. PMID: 36173355
The Role of ICL1 and H8 in Class B1 GPCRs; Implications for Receptor Activation.
Winfield I, Barkan K, Routledge S, Robertson NJ, Harris M, Jazayeri A, Simms J, Reynolds CA, Poyner DR, Ladds G. Winfield I, et al. Among authors: barkan k. Front Endocrinol (Lausanne). 2022 Jan 13;12:792912. doi: 10.3389/fendo.2021.792912. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35095763 Free PMC article.
17 results